Pharmaceutical Product Development, Llc - Net Worth and Insider Trading
Pharmaceutical Product Development, Llc Net Worth
The estimated net worth of Pharmaceutical Product Development, Llc is at least $713 dollars as of 2024-09-20. Pharmaceutical Product Development, Llc is the 10% Owner of Accentia Biopharmaceuticals Inc and owns about 7,125,213 shares of Accentia Biopharmaceuticals Inc (ABPI) stock worth over $713. Details can be seen in Pharmaceutical Product Development, Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pharmaceutical Product Development, Llc has not made any transactions after 2005-10-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pharmaceutical Product Development, Llc
Pharmaceutical Product Development, Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pharmaceutical Product Development, Llc owns 3 companies in total, including Liquidia Corp (LQDA) , Accentia Biopharmaceuticals Inc (ABPI) , and Science 37 Holdings Inc (SNCE) .
Insider Ownership Summary of Pharmaceutical Product Development, Llc
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LQDA | Liquidia Corp | 2018-07-30 | 10 percent owner |
| ABPI | Accentia Biopharmaceuticals Inc | 2005-11-02 | 10 percent owner |
| SNCE | Science 37 Holdings Inc | 2021-10-06 | 10 percent owner |
Pharmaceutical Product Development, Llc Latest Holdings Summary
Pharmaceutical Product Development, Llc currently owns a total of 1 stock. Pharmaceutical Product Development, Llc owns 7,125,213 shares of Accentia Biopharmaceuticals Inc (ABPI) as of October 27, 2005, with a value of $713.
Latest Holdings of Pharmaceutical Product Development, Llc
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ABPI | Accentia Biopharmaceuticals Inc | 2005-10-27 | 7,125,213 | 0.00 | 713 |
Holding Weightings of Pharmaceutical Product Development, Llc
Pharmaceutical Product Development, Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Pharmaceutical Product Development, Llc has made a total of 0 transactions in Accentia Biopharmaceuticals Inc (ABPI) over the past 5 years. The most-recent trade in Accentia Biopharmaceuticals Inc is the sale of 0 shares on October 27, 2005, which brought Pharmaceutical Product Development, Llc around $0.
Insider Trading History of Pharmaceutical Product Development, Llc
- 1
Pharmaceutical Product Development, Llc Trading Performance
Pharmaceutical Product Development, Llc Ownership Network
Pharmaceutical Product Development, Llc Owned Company Details
What does Liquidia Corp do?
Who are the key executives at Liquidia Corp?
Pharmaceutical Product Development, Llc is the 10 percent owner of Liquidia Corp. Other key executives at Liquidia Corp include director & 10 percent owner Paul B Manning , SVP & Commercial Scott Moomaw , and Chief Financial Officer Michael Kaseta .
Liquidia Corp (LQDA) Insider Trades Summary
Over the past 18 months, Pharmaceutical Product Development, Llc made no insider transaction in Liquidia Corp (LQDA). Other recent insider transactions involving Liquidia Corp (LQDA) include a net sale of 11,239 shares made by Jason Adair , a net sale of 12,589 shares made by Scott Moomaw , and a net sale of 28,934 shares made by Rajeev Saggar .
In summary, during the past 3 months, insiders sold 174,584 shares of Liquidia Corp (LQDA) in total and bought 487,078 shares, with a net purchase of 312,494 shares. During the past 18 months, 284,856 shares of Liquidia Corp (LQDA) were sold and 2,023,391 shares were bought by its insiders, resulting in a net purchase of 1,738,535 shares.
Liquidia Corp (LQDA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Liquidia Corp Insider Transactions
Pharmaceutical Product Development, Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Pharmaceutical Product Development, Llc. You might contact Pharmaceutical Product Development, Llc via mailing address: 929 North Front Street, Wilmington Nc 28401.
Discussions on Pharmaceutical Product Development, Llc
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
